Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › TX › Kingsville › NPI 1831242734
Clinic

South Texas Family Planning & Health Corporation

South Texas Family Planning & Health Corporation was paid $593K by Medicaid between Mar 2018 and Nov 2024, across 28 billing codes. Its largest line is S4993, Contraceptive pills for birth control — 24% of everything it billed.

33Billing provider infoSOUTH TEXAS FAMILY PLANNING & HEALTH CORPORATION
KINGSVILLE, TX 78363
33aNPI1831242734assigned 01/22/2007
28Total paid$593K
24GClaims30,946
24DCodes billed28
24AFirst – last monthMar 2018 – Nov 2024
Compared with peers

Next to other Ambulatory Family Planning Facility providers in Texas

Rank by total paid#13 of 73
Median peer was paid$144K
This provider vs. median4.1×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$10K$20K$30K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201892$906.95
201959$658.50
20204,767$111K
20217,735$160K
20229,517$174K
20237,596$131K
2024incomplete1,180$15K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
S4993 Contraceptive pills for birth control 24% 1,484 1,431 $145K
99213 Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity 15% 3,373 3,148 $89K
A4267 Contraceptive supply, condom, male, each 15% 7,327 6,598 $88K
J1050 Injection, medroxyprogesterone acetate, 1 mg 13% 1,118 1,109 $77K
99395 Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years 11% 1,127 1,111 $68K
81025 2.7% 2,452 2,340 $16K
80061 Lipid panel 2.4% 1,957 1,912 $14K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 2.3% 757 749 $14K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 2.2% 1,114 1,100 $13K
J7304 Contraceptive supply, hormone containing patch, each 1.9% 27 26 $11K
83036 Hemoglobin; glycosylated (A1C) 1.5% 1,877 1,837 $9K
G0433 Infectious agent antibody detection by enzyme-linked immunosorbent assay (elisa) technique, hiv-1 and/or hiv-2, screening 1.5% 675 665 $9K
16 more codes
99385 1.1% 102 $6K
99203 Doctor's office visit, new patient (routine) 1.0% 158 $6K
A9150 Non-prescription drugs <1% 268 $5K
G0475 Hiv antigen/antibody, combination assay, screening <1% 239 $5K
82947 <1% 1,886 $4K
81003 <1% 1,643 $3K
99202 Office or other outpatient visit for the evaluation and management of a new patient, straightforward <1% 74 $2K
85018 <1% 1,195 $2K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 63 $2K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 63 $2K
85014 <1% 913 $2K
87210 <1% 282 $1K
11982 <1% 13 $1K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 118 $568.07
90688 <1% 34 $447.01
J3490 Unclassified drugs 0% 607 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialZUNIGA, MARTHA (EXECUTIVE DIRECTOR)
Same official

Other billing entities under ZUNIGA, MARTHA

Full network →

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.